Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC
Main Category: ConferencesArticle Date: 14 Jan 2013 - 4:00 PST
Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Though making headway in developed orphan drug markets such as US, Europe, Australia and some countries in Asia, rare disease patients in the rest of the world have yet to see the light of day.
Over 400 biotechs, pharma, research institutions and regulators will gather at the World Orphan Drug Congress USA in Washington DC on April 9-11, 2013. Key speakers include Flemming Ornskov, Shire's Chief Executive Designate; Charles Johnson, Vice President, Respiratory Medicine from Vertex Pharmaceuticals; Jimmy Lin, Founder & President of the Rare Genomics Institute; and, Martine Zimmerman, Executive Director, Global Regulatory Affairs from Alexion Pharmaceuticals.
This conference and expo provides a platform for key movers and shakers of the orphan drug industry to come together and discover partnerships and collaborations to expedite orphan drugs to patients globally.
Various facets to highlight key needs of the industry are as follows:
- Pitch & Partner session for biotechs and research institutions looking for investors and partners
- Technical On-floor Seminar for orphan drug manufacturers and developers looking for better technologies, equipment and processes
- Exhibition showcase floor for technology and solution providers who have stellar offerings in the orphan drug space
- 2-day strategic conference for key decision makers from bigger biotech, pharma, regulators, globally
- How to access developing orphan drug markets globally
- How to expedite orphan drugs to rare disease patients
- How to identify partners in faster orphan drug development
- How to adapt to evolving orphan drug environments in developed US & European markets
- How to launch an orphan drug successfully
CONTACT:
Caroline Hornby,
Marketing Director Terrapinn
caroline.hornby (at) terrapinn.com
+1 646 619 1792
Visit our conferences section for the latest news on this subject.
Terrapinn is a business media company. Our products are trade exhibitions, conferences, training solutions and electronic and print publications. More information and a schedule of our events can be found at http://www.terrapinn.com.
MLA
20 Jun. 2013. <http://www.medicalnewstoday.com/releases/254901.php>
APA
http://www.medicalnewstoday.com/releases/254901.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


